Sunlenca 463.5 mg in 1.5 mL Injection
RxNorm 2625909 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Sunlenca 463.5 mg in 1.5 mL Injection (RxCUI 2625909). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Gilead Sciences, Inc. 3

Gilead Sciences, Inc.

NDC Product
Human Prescription Drug

Sunlenca
NDC 61958-3001

Generic Name
Lenacapavir Sodium
Dosage Form
Tablet, Film Coated
Route
Oral
Marketing
NDA
Active Listing
NDC Product
Human Prescription Drug

Sunlenca
NDC 61958-3002

Generic Name
Lenacapavir Sodium
Dosage Form
Kit
Route
N/A
Marketing
NDA
Active Listing
NDC Product
Human Prescription Drug

Sunlenca
NDC 61958-3005

Generic Name
Lenacapavir Sodium
Dosage Form
Kit
Route
N/A
Marketing
NDA
Active Listing